PHARMACODYNAMIC DEMONSTRATION OF IMMUNOLOGICAL TOLERANCE INDUCED BY KAN-101, A NOVEL LIVER-TARGETED THERAPY FOR COELIAC DISEASE, PERSISTS FOLLOWING DRUG CLEARANCE

Joseph Murray  1     Dina Wassaf  2     Stephanie Morgan     Stephan Kontos     Kaela Goldstein     Tom Thornley     Kristie Grebe    
1 Mayo Clinic, Rochester, United States
2 Anokion, Cambridge, United States

Topic
Hepatobiliary, IBD, Small Intestine & Nutrition

Session
Big steps for coeliac and short bowel

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing